Key Takeaways

  • Amanda Blank founded Founders Beauty Group to target an industry defined by heavy fragmentation, high recurring cash flow, and minimal institutional private equity penetration.
  • Standard market research misidentifies Botox as the primary patient entry point, missing the actual customer acquisition channel: lower-friction treatments like HydraFacials and laser hair removal.
  • Med spa platforms carry heavy regulatory overhead under Corporate Practice of Medicine rules, requiring MSO and MSA structures that generate millions of dollars in legal expenses.
  • Founders Beauty Group uses secret-shopping on acquisition targets to test operational consistency directly before committing capital to a deal.

The Funnel Fallacy in Desk Research

Most private equity teams screen aesthetic medicine platforms through generic market reports. That research often builds on flawed assumptions about real consumer habits. Blank spotted the gap early: “The report said, you know, women's first foray into med spas is going to be injectables, Botox. And I'm like, it's probably like a hydroacial or laser hair removal.”

When an investment committee assumes Botox drives top-of-funnel patient acquisition, the entire platform model warps. Botox requires a high hurdle of clinical trust, carries different margin profiles, and creates different retention mechanics than introductory aesthetic treatments. As Blank noted, “there's such a disconnect between people who are investing and looking at these businesses and people who actually understand these businesses.” Platforms that misread the patient entry sequence overpay for customer acquisition and target clinics with the wrong initial service mix.

The Healthcare Reality and the MSO Legal Burden

Generalist investors often treat med spas as specialty retail or consumer wellness storefronts. State regulators treat them differently. Under Corporate Practice of Medicine regulations, non-physicians cannot own medical clinics or employ clinical providers directly.

To build Founders Beauty Group, Blank had to establish a dual structure: a management services organization (MSO) handling administrative operations alongside a physician-owned entity under a management services agreement (MSA). That operational divide creates continuous friction and heavy legal expenses. “I'd be spending millions of dollars less on legal but it unfortunately is healthcare,” Blank said. Underestimating clinical compliance turns an attractive cash-flow thesis into an ongoing legal drain.

Diligence Through Secret Shopping

Financial data conceals unit-level operational failures that destroy clinic retention. Rather than relying solely on broker decks, historical patient metrics, and standard quality of earnings reports, Blank secret-shops prospective acquisition targets herself.

Physical diligence exposes clinical protocol lapses, booking friction, and staff turnover that financial statements mask. Med spas depend entirely on repeat bookings and local provider trust. A platform cannot fix broken unit economics through central procurement if the customer experience at acquired clinics drives first-time patients away.

Why It Matters

The med spa roll-up thesis exposes the hazard of applying pure retail consolidation playbooks to clinical operations. As institutional capital enters fragmented aesthetic medicine, platforms that treat locations as retail shops will miscalculate overhead and retention. Real returns belong to operators who recognize that patient acquisition begins with entry-level skin treatments, while corporate headquarters absorbs healthcare-grade regulatory costs.